Observational Study of OCT in a Patients Undergoing FFR

CompletedOBSERVATIONAL
Enrollment

418

Participants

Timeline

Start Date

December 11, 2012

Primary Completion Date

March 12, 2015

Study Completion Date

October 31, 2015

Conditions
Coronary Artery Disease
Interventions
DEVICE

OCT stent guidance

Participants undergoing pre- and post-PCI fractional flow reserve (FFR) and OCT

Trial Locations (36)

35233

University Hospital - Univ. of Alabama at Birmingham (UAB), Birmingham

60153

Loyola University Chicago, Maywood

Unknown

Scripps Clinic, Green Hospital, La Jolla

Florida Hospital Orlando, Orlando

Emory University Hospital, Atlanta

Central Baptist Hospital, Lexington

Baptist Health East, Louisville

St. Luke's Hospital/Mid America Heart, Kansas City

Rutgers Cardiovascular Institute, New Brunswick

Mount Sinai Medical Center, New York

Heart Hospital of Austin, Austin

Dallas VA Medical Center, Dallas

University of Texas Medical Branch at Galveston, Galveston

Swedish Medical Center, Seattle

Aurora St. Luke's Medical Center, Milwaukee

The Prince Charles Hospital, Chermside

Med. Univ. Vienna, Vienna

OLV Hospital, Aalst

Gasthuisberg Leuven, Leuven

Montreal Heart Institute, Montreal

University of Hong Kong, Hong Kong

University Hospital Brno, Brno

CHU Clermont Ferrand, Clermont-Ferrand

CHC du Marie Lannelongue, Le Plessis-Robinson

Clinique Pasteur, Toulouse

Deutsches Herzzentrum, Munich

Ospedali Riuniti di Bergamo, Bergamo

Centro Cardiologico Monzino, Milan

Ospedale San Giovanni Addolorata, Rome

Kobe University Graduate School of Medicine, Hyōgo

Nara Medical University Hospital, Nara

Osaka Saiseikai Nakatsu Hospital, Osaka

Wakayama Medical University, Wakayama

Thoraxcentre Erasmus MC, Rotterdam

Hospital Univ. Clinico San Carlos, Madrid

Royal Brompton Hospital, London

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT01663896 - Observational Study of OCT in a Patients Undergoing FFR | Biotech Hunter | Biotech Hunter